Hosted on MSN9d
FDA approves 'ketamine' nasal spray for depression — here's everything you need to knowA nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
Green Matters on MSN4d
Viral Video Reveals the Right Way to Use Flonase, Because Apparently We're All Doing It WrongA doctor explains how to correctly use Flonase nasal spray, which includes manually opening your sinuses before you spray.
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
Inquirer on MSN5d
World’s first anti-depression nasal spray receives FDA approvalThe US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
Spravato is the brand name for esketamine ... Previous research cited by the FDA found that the nasal spray showed a "statistically significant effect" on severe depression compared to those ...
The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback